FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study

Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal

US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics

California, other states join FTC bid to block Amgen deal

FTC effort to stop Amgen's Horizon takeover faces uphill fight

US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics

FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC

FTC to block Amgen's deal to acquire Horizon Therapeutics - source